Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Cited by (1,002)

Items 301–400 of 1,002

1. Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
   Thomas Koeglsperger, Svenja-Lotta Rumpf, Patricia Schließer, Felix L. Struebing, Matthias Brendel, Johannes Levin, Claudia Trenkwalder, Günter U. Höglinger, Jochen Wolfgang Herms · 2023 · Molecular Neurodegeneration
2. Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
   Valera, Elvira, Masliah, Eliezer · 2013 · Pharmacology & Therapeutics
3. Alpha‐synuclein in the appendiceal mucosa of neurologically intact subjects
   Madison T. Gray, David G. Muñoz, Douglas A. Gray, Michael G. Schlossmacher, John Woulfe · 2013 · Movement Disorders
4. Neuropathology of α‐synuclein propagation and braak hypothesis
   Heather McCann, Heidi Cartwright, Glenda Margaret Halliday · 2015 · Movement Disorders
5. Intercellular Spread of Protein Aggregates in Neurodegenerative Disease
   Davis, Albert A., Leyns, Cheryl E.G., Holtzman, David M. · 2018 · Annual Review of Cell and Developmental Biology
6. The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties
   Thomas Näsström, Therese Fagerqvist, Mikael Barbu, Mikael Karlsson, Fredrik K. Nikolajeff, Alex Kasrayan, Monica Ekberg, Lars Lannfelt, Martin Ingelsson, Joakim J. E. Bergström · 2010 · Free Radical Biology and Medicine
7. Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys
   Yunlong Tao, Scott Vermilyea, Matthew D. Zammit, Jianfeng Lü, Miles E. Olsen, Jeanette M. Metzger, Lin Yao, Yuejun Chen, Sean Phillips, James E. Holden et al. · 2021 · Nature Medicine
8. Incidence and Extent of Lewy Body-Related α-Synucleinopathy in Aging Human Olfactory Bulb
   Renpei Sengoku, Yuko Saito, Masako Ikemura, Hiroyuki Hatsuta, Yoshio Sakiyama, Kazutomi Kanemaru, Tomio Arai, Motoji Sawabe, Noriko Tanaka, Hideki Mochizuki et al. · 2008 · Journal of Neuropathology & Experimental Neurology
9. Gastrointestinal dysfunction in Parkinson’s disease: Molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation
   Metta, Vinod, Leta, Valentina, Mrudula, Kandadai Rukmini, Prashanth, L. K., Goyal, Vinay, Borgohain, Rupam, Chung-Faye, Guy, Chaudhuri, K. Ray · 2022 · Journal of Neurology
10. Aβ and tau prion-like activities decline with longevity in the Alzheimer’s disease human brain
    Atsushi Aoyagi, Carlo Condello, Jan Stöhr, Weizhou Yue, Brianna M. Rivera, Joanne C. Lee, Amanda L. Woerman, Glenda Margaret Halliday, Sjoerd G. van Duinen, Martin Ingelsson et al. · 2019 · Science Translational Medicine
11. α-Synuclein and Neuronal Cell Death
    Toru Yasuda, Yasuto Nakata, Hideki Mochizuki · 2012 · Molecular Neurobiology
12. Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein
    Shujing Zhang, Ruowei Zhu, Buyan Pan, Hong Wei Xu, Modupe F. Olufemi, Ronald J. Gathagan, Yuanxi Li, Luyan Zhang, Jasmine Zhang, Wenxuan Xiang et al. · 2023 · Nature Neuroscience
13. What causes the death of dopaminergic neurons in Parkinson’s disease?
    Dalton James Surmeier, Jaime N. Guzmán, Javier Sánchez-Padilla, Joshua A. Goldberg · 2010 · Progress in brain research
14. Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson’s disease
    Anna Pilsl, Konstanze F. Winklhofer · 2011 · Acta Neuropathologica
15. Interaction between pathogenic proteins in neurodegenerative disorders
    K. A. Jellinger · 2011 · Journal of Cellular and Molecular Medicine
16. Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
    Scarlet Gallegos, Carla R. Pacheco, Christian Peters, Carlos Opazo, Luis Gerardo Aguayo · 2015 · Frontiers in Neuroscience
17. Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread
    Gábor Géza Kovács, Leonid Breydo, Ryan J. Green, Viktor Kis, Gina Puska, Péter Lőrincz, Laura Perju‐Dumbrava, Regina Giera, Walter Pirker, Mirjam I. Lutz et al. · 2014 · Neurobiology of Disease
18. Potential Roles of Exosomes in Parkinson’s Disease: From Pathogenesis, Diagnosis, and Treatment to Prognosis
    Haiyang Yu, Tong Sun, Jing An, Lulu Wen, Fei Liu, Zhongqi Bu, Yueran Cui, Juan Feng · 2020 · Frontiers in Cell and Developmental Biology
19. The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
    Asad Jan, Nádia Pereira Gonçalves, Christian Bjerggaard Vægter, Poul Henning Jensen, Nelson Ferreira · 2021 · International Journal of Molecular Sciences
20. Lipid Peroxidation Product 4-Hydroxy-2-Nonenal Promotes Seeding-Capable Oligomer Formation and Cell-to-Cell Transfer of α-Synuclein
    Eun-Jin Bae, Dong Hwan Ho, Eunbi Park, Jin Woo Jung, Kyungcho Cho, Ji Hye Hong, He-Jin Lee, Kwang Pyo Kim, Seung‐Jae Lee · 2012 · Antioxidants and Redox Signaling
21. The prion model for progression and diversity of neurodegenerative diseases
    Barbara Elena Stopschinski, Marc I. Diamond · 2017 · The Lancet Neurology
22. α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication
    Suzana Aulić, Lara Masperone, Joanna Narkiewicz, Elisa Isopi, Edoardo Bistaffa, Elena Ambrosetti, Beatrice Pastore, Elena De Cecco, Denis Scaini, Paola Zago et al. · 2017 · Scientific Reports
23. Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
    Roberta Cascella, Alessandra Bigi, Nunilo Cremades, Cristina Cecchi · 2022 · Cellular and Molecular Life Sciences
24. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2
    Xia, Yun, Zhang, Guoxin, Kou, Liang, Yin, Sijia, Han, Chao, Hu, Junjie, Wan, Fang, Sun, Yadi, Wu, Jiawei, Li, Yunna et al. · 2021 · Brain
25. Neurodegeneration and the ordered assembly of α-synuclein
    Maria Grazia Spillantini, Michel Goedert · 2017 · Cell and Tissue Research
26. Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
    Linn Streubel-Gallasch, Veronica Giusti, Michele Sandre, Isabella Tessari, Nicoletta Plotegher, Elena Giusto, Anna Masato, Ludovica Iovino, Ilaria Battisti, Giorgio Arrigoni et al. · 2021 · Molecular Neurobiology
27. Thinking laterally about neurodegenerative proteinopathies
    Todd Eliot Golde, David Borchelt, Benoit I. Giasson, Jada M. Lewis · 2013 · Journal of Clinical Investigation
28. ɑ-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences
    Wouter Peelaerts, Luc Bousset, Veerle Baekelandt, Ronald Melki · 2018 · Cell and Tissue Research
29. Initiation and progression of α-synuclein pathology in Parkinson’s disease
    George K. Tofaris · 2022 · Cellular and Molecular Life Sciences
30. Signs of Degeneration in 12–22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
    Zuzanna Kurowska, Elisabet M. Englund, Håkan Widner, Olle Lindvall, Jiayi Li, Patrik Brundin · 2011 · Journal of Parkinson s Disease
31. Impact of omega-3 fatty acids in Parkinson's disease
    M. Bousquet, Frédéric Calon, Francesca Cicchetti · 2011 · Ageing Research Reviews
32. Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy
    Masatoshi Konno, Takafumi Hasegawa, Toru Baba, Emiko Miura, Naoto Sugeno, Akio Kikuchi, Fabienne C. Fiesel, Tsutomu Sasaki, Masashi Aoki, Yasuto Itoyama et al. · 2012 · Molecular Neurodegeneration
33. Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo
    Darren J. Schofield, Lorraine M. Irving, Laura Calò, Anna Bogstedt, Gareth Rees, Annalisa Nuccitelli, Rajesh Narwal, Marcella Petrone, Jennifer Roberts, Lee Brown et al. · 2019 · Neurobiology of Disease
34. Alpha‐synuclein propagation: New insights from animal models
    Benjamin Dehay, Miquel Vila, Erwan Bézard, Patrik Brundin, Jeffrey H. Kordower · 2015 · Movement Disorders
35. Seeding variability of different alpha synuclein strains in synucleinopathies
    Niccolò Candelise, Matthias Schmitz, Franc Llorens, Anna Villar‐Piqué, Maria Cramm, Tobias Thom, Susana Correia, José Eriton Gomes da Cunha, Wiebke Möbius, Tiago F. Outeiro et al. · 2019 · Annals of Neurology
36. Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease
    Shengnan Zhang, Yuqing Liu, Chunyu Jia, Yeh‐Jun Lim, Guoqin Feng, Enquan Xu, Houfang Long, Yasuyoshi Kimura, Youqi Tao, Chunyu Zhao et al. · 2021 · Proceedings of the National Academy of Sciences
37. The Effect of Fragmented Pathogenic α-Synuclein Seeds on Prion-like Propagation
    Tarutani, Airi, Suzuki, Genjiro, Shimozawa, Aki, Nonaka, Takashi, Akiyama, Haruhiko, Hisanaga, Shin-ichi, Hasegawa, Masato · 2016 · Journal of Biological Chemistry
38. Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved
    Eftychia Vasili, Antonio Dominguez‐Meijide, Tiago F. Outeiro · 2019 · Frontiers in Molecular Neuroscience
39. Modeling α-Synuclein Propagation with Preformed Fibril Injections
    Hyun Kyung Chung, Hoang-Anh Ho, Dayana Pérez-Acuña, Seung‐Jae Lee · 2019 · Journal of Movement Disorders
40. The neural stem cell secretome and its role in brain repair
    Cory M. Willis, Alexandra M. Nicaise, Luca Peruzzotti‐Jametti, Stefano Pluchino · 2019 · Brain Research
41. Autophagy activation promotes clearance of α-synuclein inclusions in fibril-seeded human neural cells
    Jianqun Gao, Gayathri Perera, Megha Bhadbhade, Glenda Margaret Halliday, Nicolas L. Dzamko · 2019 · Journal of Biological Chemistry
42. Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice
    Amanda N. Sacino, Mieu Brooks, Michael A. Thomas, Alex B. McKinney, Nicholas H. McGarvey, Nicola J. Rutherford, Carolina Ceballos‐Diaz, Janice Robertson, Todd Eliot Golde, Benoit I. Giasson · 2014 · Acta Neuropathologica
43. Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases
    Gianluigi Forloni, Vladimiro Artuso, Pietro La Vitola, Claudia Balducci · 2016 · Movement Disorders
44. New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
    Guoxin Zhang, Yun Fei Xia, Fang Jung Wan, Kai Ma, Xingfang Guo, Liang Kou, Sijia Yin, Chao Han, Ling Liu, Jinsha Huang et al. · 2018 · Frontiers in Aging Neuroscience
45. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases
    Ofer Sadan, Eldad Melamed, Daniel Offen · 2009 · Expert Opinion on Biological Therapy
46. Understanding amphisomes
    Dhasarathan Ganesan, Qian Cai · 2021 · Biochemical Journal
47. Circadian clocks and neurodegenerative diseases: time to aggregate?
    Michael Harvey Hastings, Michel Goedert · 2013 · Current Opinion in Neurobiology
48. Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases
    Tanmay Tanna, Vatsal Sachan · 2014 · Current Stem Cell Research & Therapy
49. α‐Synuclein oligomers oppose long‐term potentiation and impair memory through a calcineurin‐dependent mechanism: relevance to human synucleopathic diseases
    Zane S. Martin, Volker Neugebauer, Kelly T. Dineley, Rakez Kayed, Wenru Zhang, Lindsay C. Reese, Giulio Taglialatela · 2011 · Journal of Neurochemistry
50. Creutzfeldt-Jakob disease: recent developments
    Graeme M Mackenzie, Robert G Will · 2017 · F1000Research
51. Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes
    Yaping Chu, Scott Muller, Adriana Tavares, Olivier Barret, David Alagille, John Peter Seibyl, Gilles D. Tamagnan, KENNETH L. MAREK, Kelvin C. Luk, John Q. Trojanowski et al. · 2019 · Brain
52. Novel targeted therapies for Parkinson’s disease
    Theodora Ntetsika, Paraskevi-Evita Papathoma, Ioanna Markaki · 2021 · Molecular Medicine
53. α-Synuclein pathology as a target in neurodegenerative diseases
    Hye-Jin Park, Tae‐In Kam, Valina Lynn Dawson, Ted M. Dawson · 2024 · Nature Reviews Neurology
54. Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson’s disease
    Olanow, C Warren, Savolainen, Mari, Chu, Yaping, Halliday, Glenda M, Kordower, Jeffrey H · 2019 · Brain
55. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death
    A-L Mahul-Mellier, Filip Vercruysse, Bohumil Maco, Nadine Ait‐Bouziad, Mathias De Roo, Dominique Müller, Hilal Ahmed Lashuel · 2015 · Cell Death and Differentiation
56. Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders
    John Douglas Cleary, Laura P.W. Ranum · 2014 · Current Opinion in Genetics & Development
57. Mesenchymal stem cells enhance α-synuclein clearance via M2 microglia polarization in experimental and human parkinsonian disorder
    Hyun-Jung Park, Se Hee Oh, Hana Kim, Yu Ju Jung, Phil Hyu Lee · 2016 · Acta Neuropathologica
58. Alpha Synuclein: Neurodegeneration and Inflammation
    Gianluigi Forloni · 2023 · International Journal of Molecular Sciences
59. The Interplay between Alpha-Synuclein Clearance and Spreading
    Tomás Lopes da Fonseca, Anna Villar‐Piqué, Tiago F. Outeiro · 2015 · Biomolecules
60. The aggregation of mutant p53 produces prion-like properties in cancer
    Luciana Pereira Rangel, Danielly C. Ferraz da Costa, Tuane C. R. G. Vieira, Jerson Lima Silva · 2014 · Prion
61. Human-induced pluripotent stem cells: potential for neurodegenerative diseases
    Christopher A. Ross, Sergey Akimov · 2014 · Human Molecular Genetics
62. Phosphorylation induces distinct alpha-synuclein strain formation
    Meng-Rong Ma, Zhiwen Hu, Yufen Zhao, Yong‐Xiang Chen, Yanmei Li · 2016 · Scientific Reports
63. Structural and Functional Insights into α-Synuclein Fibril Polymorphism
    Surabhi Mehra, Laxmikant G. Gadhe, Riya Bera, Ajay Singh Sawner, Samir Kumar Maji · 2021 · Biomolecules
64. α‐Synuclein: The Long Distance Runner
    Sonia George, Nolwen L. Rey, Nicole Reichenbach, Jennifer A. Steiner, Patrik Brundin · 2013 · Brain Pathology
65. Cellular Regulation of Amyloid Formation in Aging and Disease
    Esther Stroo, Mandy Koopman, Ellen A. A. Nollen, Alejandro Mata‐Cabana · 2017 · Frontiers in Neuroscience
66. Potential Modes of Intercellular α-Synuclein Transmission
    Dario Valdinocci, Rowan A. W. Radford, Sue Maye Siow, Roger S. Chung, Dean L. Pountney · 2017 · International Journal of Molecular Sciences
67. The Impairments of α-Synuclein and Mechanistic Target of Rapamycin in Rotenone-Induced SH-SY5Y Cells and Mice Model of Parkinson’s Disease
    Mahesh Ramalingam, Yu-Jin Huh, Yun‐Il Lee · 2019 · Frontiers in Neuroscience
68. Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases
    Jessica Tittelmeier, Eliana Nachman, Carmen I. Nussbaum-Krammer · 2020 · Frontiers in Aging Neuroscience
69. Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
    Sindhu A. Menon, Sabrina E.M. Armstrong, Amir Mohammad Hamzeh, Naomi P. Visanji, S. Pablo Sardi, Anurag Tandon · 2022 · Frontiers in Neurology
70. Lysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models
    Ying Xue Xie, Nima N. Naseri, Jasmine A. Fels, Parinati Kharel, Yoonmi Na, Diane Lane, Jacqueline Burré, Manu Sharma · 2022 · Nature Communications
71. Conversion of Wild-type α-Synuclein into Mutant-type Fibrils and Its Propagation in the Presence of A30P Mutant
    Motokuni Yonetani, Takashi Nonaka, Masami Masuda, Yuki Inukai, Takayuki Oikawa, Shin‐ichi Hisanaga, Masato Hasegawa · 2009 · Journal of Biological Chemistry
72. Molecular analysis and biochemical classification of TDP-43 proteinopathy
    Hiroshi Tsuji, Tetsuaki Arai, Fuyuki Kametani, Takashi Nonaka, Makiko Yamashita, Masami Masuda‐Suzukake, Masato Hosokawa, Mari Yoshida, Hiroyuki Hatsuta, Masaki Takao et al. · 2012 · Brain
73. Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein
    Walker S. Jackson · 2014 · Disease Models & Mechanisms
74. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson’s disease
    Jessica Vargas, Clara Grudina, Chiara Zurzolo · 2019 · Ageing Research Reviews
75. Prions and the Potential Transmissibility of Protein Misfolding Diseases
    Allison Kraus, Bradley R. Groveman, Byron W. Caughey · 2013 · Annual Review of Microbiology
76. The more you have, the less you get: the functional role of inflammation on neuronal differentiation of endogenous and transplanted neural stem cells in the adult brain
    Patricia Mathieu, Daniela Battista, Amaicha Mara Depino, Valeria Roca, Mariana Graciarena, Fernando Juan Pitossi · 2009 · Journal of Neurochemistry
77. Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration
    Christiane Richter‐Landsberg, Janina Leyk · 2013 · Acta Neuropathologica
78. Can Parkinson's disease pathology be propagated from one neuron to another?
    Christopher J.R. Dunning, Juan F. Reyes, Jennifer A. Steiner, Patrik Brundin · 2011 · Progress in Neurobiology
79. A Nigro−Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism
    Laura Anselmi, Luca Toti, Cecilia Bove, Jessica Hampton, R. Alberto Travagli · 2017 · Gastroenterology
80. The limbic and neocortical contribution of α‐synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies
    Tanis J. Ferman, Naoya Aoki, Julia E. Crook, Melissa Erin Murray, Neill R. Graff‐Radford, Jay A. van Gerpen, Ryan J. Uitti, Zbigniew K. Wszołek, Jonathan Graff‐Radford, Otto Pedraza et al. · 2017 · Alzheimer s & Dementia
81. Neuroinvasion of α-Synuclein Prionoids after Intraperitoneal and Intraglossal Inoculation
    Breid, Sara, Bernis, Maria E., Babila, Julius T., Garza, Maria C., Wille, Holger, Tamgüney, Gültekin · 2016 · Journal of Virology
82. Interactions between iron and α-synuclein pathology in Parkinson's disease
    Bingbing Chen, Xiaoming Wen, Hong Fu Jiang, Jun Wang, Ning Song, Junxia Xie · 2019 · Free Radical Biology and Medicine
83. Multiple System Atrophy
    Gregor Karl Wenning, Stefan Braune · 2001 · CNS Drugs
84. Transmission of α-synuclein seeds in neurodegenerative disease: recent developments
    Richard J. Karpowicz, John Q. Trojanowski, Virginia M.‐Y. Lee · 2019 · Laboratory Investigation
85. Synucleinopathies: Where we are and where we need to go
    Inês Caldeira Brás, Antonio Dominguez‐Meijide, Ellen Gerhardt, David J. Koss, Diana F. Lázaro, Patrícia I. Santos, Eftychia Vasili, Mary Xylaki, Tiago F. Outeiro · 2020 · Journal of Neurochemistry
86. Neurodegenerative disorders and gut-brain interactions
    Alpana Singh, Ted M. Dawson, Subhash Kulkarni · 2021 · Journal of Clinical Investigation
87. Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease
    Hilary Grosso Jasutkar, Stephanie E. Oh, M. Maral Mouradian · 2022 · Pharmacological Reviews
88. Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology
    Trevor Tyson, Jennifer A. Steiner, Patrik Brundin · 2015 · Journal of Neurochemistry
89. Dissecting the potential molecular mechanisms underlying α-synuclein cell-to-cell transfer in Parkinson's disease
    Élodie Angot, Patrik Brundin · 2009 · Parkinsonism & Related Disorders
90. The remarkable conformational plasticity of alpha-synuclein: blessing or curse?
    Angélique Deleersnijder, Melanie Gérard, Zeger Debyser, Veerle Baekelandt · 2013 · Trends in Molecular Medicine
91. Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling
    Philipp Koch, Zaal Kokaia, Olle Lindvall, Oliver Brüstle · 2009 · The Lancet Neurology
92. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis
    Cédric Boucherie, Sabrina Schäfer, Patricia M. Lavand'homme, Jean‐Marie Maloteaux, Emmanuel Hermans · 2009 · Journal of Neuroscience Research
93. Lewy body pathology in fetal grafts
    Yaping Chu, Jeffrey H. Kordower · 2009 · Annals of the New York Academy of Sciences
94. Parkinson's Disease – the Debate on the Clinical Phenomenology, Aetiology, Pathology and Pathogenesis
    Peter G. Jenner, Huw R. Morris, Trevor William Robbins, Michel Goedert, John Hardy, Yoav Ben‐Shlomo, J. Paul Bolam, David John Burn, John Vincent Hindle, David James Brooks et al. · 2013 · Journal of Parkinson s Disease
95. Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
    Naomi P. Visanji, Anthony Edward Lang, Gábor Géza Kovács · 2019 · Translational Neurodegeneration
96. Sodium butyrate causes α-synuclein degradation by an Atg5-dependent and PI3K/Akt/mTOR-related autophagy pathway
    Chen-Meng Qiao, Mengfei Sun, Xue-Bing Jia, Yun Wei Shi, Bo-Ping Zhang, Zhi-Lan Zhou, Liping Zhao, Chun Cui, Yan‐Qin Shen · 2019 · Experimental Cell Research
97. Towards stem cell replacement therapies for Parkinson's disease.
    E. Arenas · 2010 · Biochemical and Biophysical Research Communications - BBRC
98. Adult neural stem cells: an endogenous tool to repair brain injury?
    Gian Carlo Bellenchi, Floriana Volpicelli, Valerio E. C. Piscopo, Carla Perrone‐Capano, Umberto di Porzio · 2012 · Journal of Neurochemistry
99. Immunotherapy for Parkinson’s disease
    Aaron D. Schwab, Mackenzie J. Thurston, Jatin Machhi, Katherine E. Olson, Krista L. Namminga, Howard Eliot Gendelman, Rodney Lee Mosley · 2020 · Neurobiology of Disease
100. Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities
     Tae Wan Kim, So Yeon Koo, Lorenz Studer · 2020 · Frontiers in Cell and Developmental Biology